Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs Thoracic Epidural for Post-Mastectomy Pain
NCT06884852Recruiting
- Sponsor
- National Cancer Institute
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in Post-mastectomy pain syndrome (PMPS) and pain (2 arms), sponsored by National Cancer Institute. Primary endpoint: Average duration of analgesia. Started Mar 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
Post-mastectomy pain syndrome (PMPS)pain
Beyond the preview
Go deeper on NCT06884852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06884852.